|
CLK4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.45689999999588E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.780270E-04 |
| Normal-vs-Stage2 |
1.719500E-02 |
| Normal-vs-Stage3 |
2.697600E-01 |
| Normal-vs-Stage4 |
1.822950E-01 |
| Stage1-vs-Stage2 |
4.641200E-01 |
| Stage1-vs-Stage3 |
8.788300E-02 |
| Stage1-vs-Stage4 |
8.963200E-01 |
| Stage2-vs-Stage3 |
8.182100E-02 |
| Stage2-vs-Stage4 |
6.270000E-01 |
| Stage3-vs-Stage4 |
3.698200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.371650E-04 |
| Normal-vs-AfricanAmerican |
4.200300E-04 |
| Normal-vs-Asian |
1.024610E-01 |
| Caucasian-vs-AfricanAmerican |
5.308400E-01 |
| Caucasian-vs-Asian |
9.407600E-01 |
| AfricanAmerican-vs-Asian |
7.809000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.62480000000165E-05 |
| Normal-vs-Female |
8.155600E-03 |
| Male-vs-Female |
2.188800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.060300E-02 |
| Normal-vs-Extreme_Weight |
1.776450E-04 |
| Normal-vs-Obese |
1.041360E-03 |
| Normal-vs-Extreme_Obese |
3.049900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.531800E-01 |
| Normal_Weight-vs-Obese |
4.371800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.717400E-01 |
| Extreme_Weight-vs-Obese |
6.724800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.279400E-01 |
| Obese-vs-Extreme_Obese |
9.955200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.581900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.93629999945789E-07 |
| Normal-vs-Age(61-80Yrs) |
3.718000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.232620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.226000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.720000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.486000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.039400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.041800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.869600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.24809999691689E-08 |
| Normal-VS-Type2 PRCC |
3.444400E-01 |
| Normal-VS-KIRP CIMP |
1.518570E-01 |
| Normal-VS-Unclassified PRCC |
9.945000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.06960000004308E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.59639999500294E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
2.063000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.719600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.155500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.561520E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.039800E-02 |
| Normal-vs-N1 |
1.195210E-01 |
| Normal-vs-N2 |
8.397400E-01 |
| N0-vs-N1 |
8.968400E-01 |
| N0-vs-N2 |
4.291400E-01 |
| N1-vs-N2 |
5.675600E-01 |
|
|
